BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9769944)

  • 21. Activation of the transcription factor Oct-1 in response to DNA damage.
    Zhao H; Jin S; Fan F; Fan W; Tong T; Zhan Q
    Cancer Res; 2000 Nov; 60(22):6276-80. PubMed ID: 11103783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox modulation of p53: mechanisms and functional significance.
    Kim DH; Kundu JK; Surh YJ
    Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53 pathway: positive and negative feedback loops.
    Harris SL; Levine AJ
    Oncogene; 2005 Apr; 24(17):2899-908. PubMed ID: 15838523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 protein or BID protein select the route to either apoptosis (programmed cell death) or to cell cycle arrest opposing carcinogenesis after DNA damage by ROS.
    Wiseman A
    Med Hypotheses; 2006; 67(2):296-9. PubMed ID: 16580789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-translational modification of p53.
    Meek DW
    Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures and functions of the tumor suppressor p53.
    Milner J
    Pathol Biol (Paris); 1997 Dec; 45(10):797-803. PubMed ID: 9769943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DNA binding regulatory domain of p53: see the C.
    Wolkowicz R; Rotter V
    Pathol Biol (Paris); 1997 Dec; 45(10):785-96. PubMed ID: 9769942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance.
    Chiarugi V; Cinelli M; Magnelli L
    Oncol Res; 1998; 10(2):55-7. PubMed ID: 9666512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53.
    Montenarh M
    Crit Rev Oncog; 1992; 3(3):233-56. PubMed ID: 1616956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The yin and yang of p53 in cellular proliferation.
    Deppert W
    Semin Cancer Biol; 1994 Jun; 5(3):187-202. PubMed ID: 7948947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisite phosphorylation and the integration of stress signals at p53.
    Meek DW
    Cell Signal; 1998 Mar; 10(3):159-66. PubMed ID: 9607138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 isoforms gain functions.
    Olivares-Illana V; FĂ„hraeus R
    Oncogene; 2010 Sep; 29(37):5113-9. PubMed ID: 20622898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of p53--insights into a complex process.
    Boehme KA; Blattner C
    Crit Rev Biochem Mol Biol; 2009; 44(6):367-92. PubMed ID: 19929178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-translational modifications and activation of p53 by genotoxic stresses.
    Appella E; Anderson CW
    Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signalling to p53: where does it all start?
    Kastan MB
    Bioessays; 1996 Aug; 18(8):617-9. PubMed ID: 8760334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in the multi-site phosphorylation and integration of stress signalling at p53.
    Meek DW
    Int J Radiat Biol; 1998 Dec; 74(6):729-37. PubMed ID: 9881718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation at carboxyl-terminal S373 and S375 residues and 14-3-3 binding are not required for mouse p53 function.
    Lee MK; Sabapathy K
    Neoplasia; 2007 Sep; 9(9):690-8. PubMed ID: 17898864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another fork in the road--life or death decisions by the tumour suppressor p53.
    Carvajal LA; Manfredi JJ
    EMBO Rep; 2013 May; 14(5):414-21. PubMed ID: 23588418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.
    Liebermann DA; Hoffman B; Vesely D
    Cell Cycle; 2007 Jan; 6(2):166-70. PubMed ID: 17264673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.